Challenges and opportunities in bringing non-HLA antibody testing for post-transplant monitoring [0.03%]
移植后监测中非HLA抗体检测的挑战与机遇分析
Mary Carmelle Philogene,Inna Tchoukina,Idoia Gimferrer
Mary Carmelle Philogene
Evidence for the contribution of non-HLA antibodies on long-term allograft outcome was suggested in early studies by Paul Terasaki and colleagues who showed worse 10-year allograft outcome in HLA identical kidney transplant recipients with ...
Males and females respond differently to treatment during isolated kidney perfusion: combined effects of glucocorticoid and estradiol [0.03%]
糖皮质激素和雌二醇对孤立灌注肾脏的联合效应及男女差异响应反应的研究
Marina Vidal-Dos-Santos,Roberto Armstrong-Jr,Mayara Munhoz de Assis Ramos et al.
Marina Vidal-Dos-Santos et al.
Background: Kidney perfusion is a tool that allows organs to be assessed before transplantation. After brain death (BD), hormonal dysfunction can compromise graft quality. Hormonal treatment of donors has shown positive o...
Exhaled breath particles as a diagnostic tool for bronchiolitis obliterans syndrome in lung transplant recipients: a longitudinal study [0.03%]
接受者外源呼吸颗粒作为肺移植受者的气道闭塞症的诊断工具：一项纵向研究
Runchuan Gu,Embla Bodén,Sandra Lindstedt et al.
Runchuan Gu et al.
Background: Long-term survival after lung transplantation is significantly shorter compared with other solid organ transplantations. Chronic lung allograft dysfunction (CLAD), including bronchiolitis obliterans syndrome (...
Research on the evaluation system of prosthesis structure type implanted with porous structure [0.03%]
多孔结构假体结构类型的评价体系研究
Ye Zhu,Yong Jiang,Lei Lei et al.
Ye Zhu et al.
The porous structure can effectively reduce the stress shielding effect in the process of implanting prostheses in the treatment of bone defects, but the performance of different types of porous structures directly affects the treatment eff...
Long-term outcomes of a case-control lung transplant cohort after SARS-CoV-2 infection [0.03%]
SARS-CoV-2感染后肺移植病例对照队列的长期结局
Sandrine Hanna,Rami Hallak,Susanna M Leonard et al.
Sandrine Hanna et al.
Background: Respiratory viruses can impact the allograft function in lung transplant recipients, but it is unknown if this occurs with SARS-CoV-2 infection. We studied the long-term outcomes of lung transplant recipients ...
Incidence of catheter-related bloodstream infection (CRBSI) in immunosuppressed hosts post solid organ transplant (SOT): a single center experience [0.03%]
免疫抑制状态器官移植受者导管相关血流感染的单中心研究进展
Christopher El Mouhayyar,Ayman Al Jurdi,Kassem Safa
Christopher El Mouhayyar
Introduction: Catheter-related bloodstream infections (CRBSI) incidence is well-studied in general hemodialysis patients. There is a lack of data on CRBSI rates specifically in solid organ transplant (SOT) recipients requ...
Case Report: Donor-derived herpes simplex virus type 1 hepatitis in a kidney transplant recipient with fatal outcome [0.03%]
个案报告：肾移植受者HSV-1性肝炎并发多器官感染致死病例
Jørn Petter Lindahl,Christina Dörje,Grete Birkeland Kro et al.
Jørn Petter Lindahl et al.
Current screening practices have significantly reduced the transmission of donor-derived infections through organ transplantations. However, in exceptional cases, a deceased donor may harbor an undetected active infection, or abnormal blood...
Using a combination of biomarkers to monitor allograft dysfunction in lung transplant recipients [0.03%]
联合使用生物标志物监测肺移植受者的同种异体移植物功能障碍
Zein Kattih,Shambhu Aryal
Zein Kattih
Allograft dysfunction is a major limitation of survival in organ transplant recipients including those who have received lung transplantation. Early detection of allograft dysfunction is thus crucial to improve outcomes in these patients. H...
Metabolomic and proteomic analyses of renal function after liver transplantation [0.03%]
代谢组学和蛋白质组学分析肝移植后的肾功能变化
Xiaoling Wang,Nadja Grobe,Barbara Franchin et al.
Xiaoling Wang et al.
Background: Renal dysfunction is a common and serious complication in patients with end-stage liver diseases. While some patients recover renal function after liver transplantation (LT), others do not. Additionally, patie...
Regulated cell death and DAMPs as biomarkers and therapeutic targets in normothermic perfusion of transplant organs. Part 2: implementation strategies [0.03%]
调节性细胞死亡和DAMPs作为正常体温灌注中器官移植生物标志物和治疗靶点的实施策略（第二部分）
Walter G Land,Andreas Linkermann
Walter G Land
This Part 2 of a bipartite review commences with the delineation of a conceptual model outlining the fundamental role of injury-induced regulated cell death (RCD) in the release of DAMPs that drive innate immune responses involved in early ...